Ключевые слова:
trigeminal neuralgia; central sensitization; autonomic dysfunction; psychoemotional dysfunction; anxiety; depression; sleep disturbance; quantitative sensory testing; neuroplasticity; neuropathic pain; quality of life.Библиографические ссылки
1. Jeong YD, Jo Y, Son Y, Kim DK, Kim TH, Cho J, Kim S, Kang J, Smith L, Woo HG, Yon DK. Global incidence and prevalence of trigeminal neuralgia, 1945–2024: a systematic review and meta-regression analysis. Journal of Clinical Neurology. 2026;22 (1):102–112.
2. de Toledo IP, Réus JC, Fernandes M, Porporatti AL, Peres MA, Takaschima A, Linhares MN, Guerra E, Canto GDL. Prevalence of trigeminal neuralgia: a systematic review. Journal of the American Dental Association. 2016;147(7):570–576.e2.
3. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain. 2001;124(12): 2347–2360.
4. Love S, Hilton DA, Coakham HB. Central demyelination of the Vth nerve root in trigeminal neuralgia associated with vascular compression. Brain Pathology. 1998;8(1):1–11.
5. Cruccu G, Finnerup NB, Jensen TS, Scholz J, Sindou M, Svensson P, et al. Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology. 2016;87(2):220–228.
6. Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A, et al. European Academy of Neurology guideline on trigeminal neuralgia. European Journal of Neurology. 2019;26 (6):831–849.
7. Di Stefano G, Maarbjerg S, Truini A, Cruccu G. Trigeminal neuralgia. New England Journal of Medicine. 2020;383(8):754–762.
8. Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia: diagnosis and treatment. Cephalalgia. 2017;37(7):648–657.
9. Rappaport MS, et al. Subtle sensory abnormalities detected by quantitative sensory testing in patients with trigeminal neuralgia. Regional Anesthesia and Pain Medicine. 2016.
10. Quantitative sensory testing identifies altered thermal and pain processing in trigeminal neuralgia. European Journal of Neurology. 2026.
11. Henssen D, Dijk J, Knepflé R, Sieffers M, Winter A, Vissers K. Alterations in grey matter density and functional connectivity in trigeminal neuropathic pain and trigeminal neuralgia: a systematic review and meta-analysis. NeuroImage: Clinical. 2019; 24:102039.
12. Structural and functional brain abnormalities in trigeminal neuralgia: a systematic review. Frontiers in Neurology. 2020.
13. Nardoni L, Tullo MG, Di Stefano G, Fiorelli M, Caramia F. Structural brain alterations and changes in resting-state functional connectivity in patients with trigeminal neuralgia: a meta-analysis. NeuroImage: Clinical. 2025;46:103759.
14. Yang H, Zhang C, Sun B, et al. Abnormal regional brain functional activity and brain network connectivity in primary trigeminal neuralgia patients: an activation likelihood estimation meta-analysis based on resting-state functional magnetic resonance imaging. 2026.
15. Léonard G, Chalaye P, Goffaux P, Mathieu D, Gaumond I, Marchand S. Altered autonomic nervous system reactivity to pain in trigeminal neuralgia. Canadian Journal of Neurological Sciences. 2015;42(2): 125–131.
16. Melek LN, Devine M, Renton T. The psychosocial impact of orofacial pain in trigeminal neuralgia patients: a systematic review. International Journal of Oral and Maxillofacial Surgery. 2018;47(7):869–878.
17. Chen YY, et al. Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study. Journal of Headache and Pain. 2015.
18. Unraveling the relationship between facial neuropathic conditions and pain, sleep, chronotypes, bruxism, and psychosocial factors. PubMed-indexed clinical study. 2025.
19. Dalessandris QG, et al. Psychological assessment in patients affected by trigeminal neuralgia: a systematic review. Acta Neurochirurgica. 2025.
20. Therapeutic approach for trigeminal neuralgia: a systematic review. Biomedicines. 2023;11 (10):2606.
21. Yang Y, Shang H, Han T. Evaluation of carbamazepine and gabapentin's safety and efficacy in trigeminal neuralgia treatment: a systematic review and meta-analysis. Current Pharmaceutical Design / Bentham Science. 2026;29(5):829–838.
22. Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32(6):443–450.
23. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: a systematic review. PubMed-indexed systematic review. 2024.
24. Di Carlo DT, Benedetto N, Perrini P. Clinical outcome after microvascular decompression for trigeminal neuralgia: a systematic review and meta-analysis. Neurosurgical Review. 2022;46(1):8.
25. The long-term outcome of microvascular decompression for trigeminal neuralgia. Journal of Neurosurgery. 2010.
26. Long-term therapeutic effect of microvascular decompression for trigeminal neuralgia: Kaplan-Meier analysis in a consecutive series of 425 patients. Turkish Neurosurgery. 2016.
27. Recurrence rates after microvascular decompression in patients with primary trigeminal neuralgia and its influencing factors: a systematic review and meta-analysis based on 8,172 surgery patients. Frontiers in Neurology. 2021.
28. Comparison of the neuropathic pain symptoms and psychosocial impacts of trigeminal neuralgia and painful posttraumatic trigeminal neuropathy. Journal of Oral & Facial Pain and Headache. 2019.
29. Update on trigeminal neuralgia. Current Pain and Headache Reports. 2019.
30. Joint European Academy of Neurology–European Pain Federation–Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment. European Journal of Neurology. 2023.
